Education
About Us
Working with TipRanks
Follow Us
Harima B.Stem Corporation (JP:9780)
:9780
RESEARCH TOOLSreports
Top Page
Harima B.Stem Corporation
(9780)
Rating:70Outperform
Price Target:―
Harima B.Stem Corporation (9780) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.79B
Dividend Yield3.68%
Average Volume (3M)11.56K
Price to Earnings (P/E)7.5
Beta (1Y)0.39
Revenue Growth4.13%
EPS Growth9.17%
CountryJP
Employees1,701
SectorIndustrials
Sector Strength90
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)28.65
Shares Outstanding9,624,490
10 Day Avg. Volume23,700
30 Day Avg. Volume11,556
Financial Highlights & Ratios
PEG Ratio-2.83
Price to Book (P/B)0.73
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Harima B.Stem Corporation Business Overview & Revenue Model
Company DescriptionHarima B.Stem Corporation (9780) is a Japanese company primarily engaged in the manufacturing and distribution of chemical products. The company operates in various sectors, including chemicals and materials, offering a diverse range of products that cater to different industrial applications. Key offerings include specialized chemicals used in adhesives, coatings, and other industrial processes. Harima B.Stem Corporation is known for its innovative solutions and commitment to quality, serving both domestic and international markets.
How the Company Makes MoneyHarima B.Stem Corporation generates revenue through the sale of its chemical products to various industries. The company's primary revenue streams include the production and distribution of adhesives, coatings, and other industrial chemicals that are essential in manufacturing processes across different sectors. Harima B.Stem maintains strategic partnerships and collaborates with other companies to enhance its product offerings and expand its market reach. By leveraging its expertise in chemical manufacturing, the company capitalizes on its ability to supply high-quality products that meet the specific needs of its clients, thus driving sales and profitability.
Harima B.Stem Corporation Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 27.43B | 26.62B | 25.32B | 25.00B | 24.18B | 23.34B | Gross Profit |
| 3.68B | 3.46B | 3.13B | 3.15B | 2.89B | 2.70B | EBIT |
| 1.01B | 964.92M | 813.72M | 901.17M | 679.45M | 554.00M | EBITDA |
| 1.13B | 1.19B | 1.15B | 1.12B | 1.10B | 638.00M | Net Income Common Stockholders |
| 790.69M | 756.83M | 736.50M | 788.69M | 642.14M | 438.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 5.60B | 4.21B | 3.94B | 3.93B | 3.95B | 3.05B | Total Assets |
| 14.98B | 14.13B | 12.48B | 12.25B | 12.05B | 10.62B | Total Debt |
| 965.00M | 729.72M | 656.59M | 1.14B | 1.38B | 984.19M | Net Debt |
| -4.64B | -3.48B | -3.29B | -2.80B | -2.57B | -1.47B | Total Liabilities |
| 6.05B | 5.60B | 4.72B | 5.18B | 5.53B | 4.73B | Stockholders Equity |
| 8.93B | 8.46B | 7.70B | 7.01B | 6.46B | 5.84B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 491.33M | 436.01M | 586.12M | 607.84M | -83.79M | Operating Cash Flow |
| 0.00 | 1.18B | 966.52M | 665.75M | 760.39M | 317.92M | Investing Cash Flow |
| 0.00 | -849.86M | -359.09M | -59.90M | -229.81M | -723.88M | Financing Cash Flow |
| 0.00 | -58.16M | -595.95M | -627.72M | 371.19M | -33.22M |
Harima B.Stem Corporation Technical Analysis
Positive
705.00
Price Trends
694.44
Positive
694.17
Positive
702.80
Positive
Market Momentum
3.02
Negative
56.52
Neutral
76.49
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9780, the sentiment is Positive. The current price of 705 is above the 20-day moving average (MA) of 698.00, above the 50-day MA of 694.44, and above the 200-day MA of 702.80, indicating a bullish trend. The MACD of 3.02 indicates Negative momentum. The RSI at 56.52 is Neutral, neither overbought nor oversold. The STOCH value of 76.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9780.
Harima B.Stem Corporation Peers Comparison
Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥84.95B | 13.64 | 1.50% | 54.92% | 172.49% | ||
74 Outperform | ¥15.74B | 9.09 | 0.63% | -12.13% | 291.07% | ||
74 Outperform | €42.41B | 10.16 | 24.76% | 3.60% | 0.07% | -8.81% | |
73 Outperform | €29.91B | 17.04 | 20.74% | 1.09% | 1.45% | -0.74% | |
70 Outperform | ¥6.79B | 7.48 | 3.68% | 4.13% | 9.17% | ||
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% |
* Industrials Sector Average
Performance Comparison
JP:9780
Harima B.Stem Corporation
705.00
-14.57
-2.02%
JP:6080
M&A Capital Partners Co. Ltd.
2,681.00
642.46
31.52%
JP:6095
MedPeer, Inc.
708.00
131.44
22.80%
JP:6071
IBJ
732.00
147.69
25.28%
JP:6058
VECTOR Inc.
914.00
-353.48
-27.89%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.